MOLN
Molecular Partners AG ADR
NASDAQ: MOLN · HEALTHCARE · BIOTECHNOLOGY
$4.23
-4.94% today
Updated 2026-04-30
Market cap
$162.74M
P/E ratio
—
P/S ratio
158.42x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$3 – $5
Volume
0.0M
Molecular Partners AG ADR (MOLN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.61M | $-11.33M | $26.50M | $-35.38M | $-40.02M | $-42.47M | $-1.19M | $-28.98M | $-90.95M | $118.57M | $-59.01M | $-59.25M | $-51.26M |
| Capital expenditures | $1.47M | $546103.00 | $1.39M | $1.10M | $500000.00 | $867000.00 | $1.86M | $1.68M | $1.31M | $1.42M | $575000.00 | $723000.00 | $714000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $831754.00 | $2.27M | $3.76M | $2.85M | $3.59M | $3.72M | $2.44M | $2.93M | $4.08M | $5.09M | $5.21M | $4.11M | $4.42M |
| Free cash flow | $-15.08M | $-11.88M | $25.11M | $-36.48M | $-40.52M | $-43.34M | $-3.05M | $-30.67M | $-92.26M | $117.15M | $-59.58M | $-59.97M | $-51.97M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | $250000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — |